Actives & Intermediates
Formulation Development
Home > CRAMS > R & D > Actives & Intermediates

Focus Areas

  • Cost optimization
  • Synthesis of intermediates
  • Developing non-infringing processes for APIs
  • Improvement of processes for existing products in order to achieve ICH guidelines

Capabilities

  • Independent chemical synthesis rooms (US Class 100,000 conditions) with walk-in fume-cupboards.
  • Separate area for development of Cytotoxic Products
  • Containment facilities for synthesis of highly toxic and highly potent materials.
  • Capable of preparing API's suitable for preclinical and toxicological testing.
  • Scale-up of API manufacture to GMP standards for clinical use
  • Capable of carrying out process validation to FDA standards
  • Dedicated analytical laboratory with state of art instrumentation to support development.
  • Capaple of carrying out specialized reactions & operations requiring: Cryogenic reactor, autoclaves, loop reactors, falling film evaporators, agitated thin film evaporator, high pressures and ozone

Reaction Handling Capabilities

  • Hydrogenation
  • Oxidation
  • Reduction
  • Sulphonation
  • Nitration
  • Halogenation
  • Chloro-sulphonation
  • Condensation
  • Friedel kraft
  • Benzoylation
  • Amination
  • Alkylation
  • Grignard
  • Di-azotization
 
 
       
 
© 2006-2009 Sharon Bio-Medicine Ltd.Website By: ETrends India